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1. Introduction 
A variety of isozyme patterns are observed, on 
electrophoresis, in alkaline phosphatase ofEs&erichia 
coli K-l 2 [ 11. The molecular mechanism of isozyme 
formation has been elucidated as follows: The isozyme 
1, with extra arginine residues at the amino-terminal 
position, is first synthesized and then the residues are 
removed, resulting in the formation of isozymes 2 
and 3 in the bacterial cell [2-41. A mutant strain, 
producing only isozyme 1 and a small amount of 
isozyme 2 [4,5], is supposed to be defective in the 
proteolytic enzyme which removes the amino-terminal 
arginine residues from isozymes 1 and 2. 
Here we report that the conversion of isozymes 
was inhibited unexpectedly by endopeptidase inhibi- 
tors, antipain and leupeptin, but not by other inhibi- 
tors tested, including bestatin, an inhibitor of amino- 
peptidase B. 
2. Materials and methods 
Escherichia coli strain Kl 0, a derivative of K-l 2, 
was used in this study. 
A TG medium [6], a mineral salt solution buffered 
with Tris-HCl at pH 7.2 and containing 0.2% glucose 
was supplemented with excess phosphate (6.4 X 10e4 M). 
Casamino acids (2 mg/ml) and arginine (200 pg/ml) 
were also added to the medium, if necessary. 
Protease inhibitors were obtained from the Institute 
of Microbial Chemistry, Tokyo. They were inhibitors 
of serine-thiol protease, antipain [7], leupeptin [8,9], 
chymostatin [lo], elastatinal [ 111; inhibitor of 
carboxypeptidase, pepstatin [ 121; inhibitor of amino- 
peptidase B, bestatin [ 131. Oligopeptides were pur- 
chased from Sigma Chemical Co. 
To prepare alkaline phosphatase sample for electro- 
phoresis, the cells were washed once and resuspended 
in 0.01 M Tris-HCl (pH 7.2) containing 10m3 M 
MgSO, (TM buffer) and disrupted with sonication. 
The cell lysate was then heated in a hot water bath 
(2 80°C) for 20 min and the supernatant was applied 
on electrophoresis. 
A 7.5% polyacrylamide gel electrophoresis [ 141 
was performed at a constant 300 V for 3 h at room 
temperature. After electrophoresis, the gel was stained 
for alkaline phosphatase activities by soaking in a 
mixture of naphtol-AS-MX-phosphate and fast 
blue RR salts in 0.1 M Tris-HCl (pH 8.0) [ 15 1. 
3. Results and discussion 
In Escherichia coli alkaline phosphatase, two 
typical isozyme patterns are observed, on electropho- 
resis, depending on the nutritional conditions during 
phosphate starvation (synthesis of the enzyme). All 
3 main isozymes are observed when the enzyme 
sample is prepared from the cells grown in the presence 
of casamino acids or arginine, but only one (isozyme 3, 
the most negatively charged band of the 3) is observed 
in the absence of these agents [5 ,16,17]. The con- 
version of isozyme patterns occurs, when the cells 
are transfered from the former condition to the latter, 
even when further synthesis of the enzyme is repress- 
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ed by addition of excess phosphate. Thus, the con- 
version is apparently inhibited by arginine or casamino 
acids (see @.I, lanes I JO), 
Recently, we isoiated a mutant strain deficient in 
the isozyme conversion. The mutation (iap) was 
mapped on 58.5 nun of E. coli genetic map [ 181, an 
opposite of alkaline phosphatase structural gene 
(‘J&I&). The an~ino-tern~~na~ amino acid sequence in 
isozyme I’ synthesized in the mutant strain was the 
same as that. in the wild-type strain [2], in spite of 
the altered mobility caused by the pseudo wild-type 
structural gene of alkaline phosphatase [3]. These 
results suggest hat the iap gene product removes the 
an~ino-terminal arginine residues from isozymes 1 
and 2. 
We examined the effects of various protease inhib- 
itors on isnzyme conversion. The exponentially 
growing bacteria in TG medium supplemented with 
excess phosphate, casamino acids and arginine were 
transfered into the same medium without supple- 
mented phosphate. After 9 h incubation at 37OC, the 
cells were harvested and resuspended into the same 
medium with excess phosphate (without casarnino 
acids and arginine), to repress further synthesis of the 
enzyme. To the bacterial suspension, protease inhibi- 
tors were added, and then incubated further 14 h. As 
shown in fig.1, the conversion of isozynte pattern was 
+ 
I 2 3 9 5 6 7 a 9 IO 
Fig. I. ~olya~r~i~rn~de gel lectrophorcsis of E. edi ddine 
phosghtase. The bacteria! c&s were grown under phosphate 
starvation in the presence of casamino acids and a&nine, (II; 
and then transfered into fresh medium supplemented with 
excess phosphate fallowed by further incubation, (2); with 
400 pg/ml each of antipain, (3); bestatin, (4); chymostatm, 
(5); elastatinat, (6); Ieupeptin, (8); pepstatin, (9); casamino 
acids and arginine, (IO). 
r3g.2. Densitometric scan at 600 rim of electrophoretie gel 
stained for alkaline phosphatase activities. The experimentd 
procedure was the same as fig. 1. (l), after phosphate starva- 
tion with casamino acids and arginine (before further incuba- 
tion); (2) to (6), after further incubation. (2), with casamino 
acids and arginine; (3), antipain (3.3 mM); (4), leupeptin 
(3.3 mMvIf; (S), arginine (10 mMf; and (6), without inhibitor, 
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inhibited by antipain (lane 3) and leupeptin (lane S), 
as well as casamino acids and arginine (lane lo), but 
not by other protease inhibitors including bestatin 
(lane 4) an aminopeptidase B inhibitor. 
To test whether the synthesis of alkaline phos- 
phatase was influenced by the protease inhibitors, the 
inhibitors were added to the bacterial culture at a 
final concentration of 400 pg/ml, during starvation of 
phosphate. After overnight incubation, no remarkable 
difference of the residual growth of the cells during 
phosphate starvation nor the enzyme activities were 
observed. The same isozyme patterns as in fig.1 were 
observed after electrophoresis. 
For the comparison of various agents on inhibition 
of isozyme conversion, densitometric scan was per- 
formed on polyacrylamide gel stained for alkaline 
phosphatase activities and the area of each isozyme 
peak was measured (fig.2). Since it has been reported 
that the isozymes 1 and 3 consist of two homologous 
polypeptides with and without amino-terminal 
arginine, respectively, and isozyme 2 is composed of 
one monomer of isozyme 1 and one monomer of 
isozyme 3 [ 17,191, the average number of remaining 
arginine residues in amino-terminal position (N) after 
incubation with various agents were calculated as 
follows: 
area 1 X 2 + area 2 
N= 
’ areas 1 + 2 t 3 
As shown in table I, antipain and leupeptin inhib- 
ited conversion at a lower concentration than arginine. 
A dipeptide, L-arginyl-L-aspartic acid revealed a 
similar effect as the latter. Less effective inhibition 
was observed in canavaine, L-glycyl-Lglycyl-L- 
tyrosyl-L-arginine, p-aminobenzamidine (PAB), N-W 
p-tosyl--L-lysine chloromethyl ketone (TLCK) and 
p-tosyl-L-arginine methyl ester (TAME). No inhibi- 
tion was observed in chymostatin, elastatinal, bestatin, 
pepstatin, aprotinine (Trasylol), N-al-p-tosyl-L-lysine 
methyl ester (TLME), N-cr-p-tosyl-L-arginine amide 
and dipeptides containing no arginine residue. 
It is noteworthy that the inhibitors of endopepti- 
dase, antipain, leupeptin and PAB, inhibited isozyme 
conversion, whereas, an inhibitor of aminopeptidase 
B, bestatin did not. This result was unexpected since 
isozyme conversions were brought about by removing 
the amino-terminal arginine residues. 
It might be possible that the activity of a new type 
protease, presumably a product of iap gene, isinhibited 
by these protease inhibitors or that the gene product 
requires proteolysis for its activation and the activa- 
tion is inhibited by the protease inhibitors. 
Table 1 
Inhibition of isozyme conversion in vivoa 
Inhibitor Concentration (mM) 
0 0.1 0.33 1.0 3.3 10.0 
-(before incubation) 
-(after incubation) 
-(standing in cold) 
Antipain 
Leupeptin 
Arginine 
Canavanine 
L-Arginyl-L-aspartic acid 
L-GlycyI-L-glycyl- 
L-tyrosyl-L-arginine 
TAME 
TLCK 
p-Aminobenzamidine 
1.17 
0.23 
0.39 
0.66 1.04 1.21 1.24 
0.81 1.06 1.18 1.20 
0.38 1.06 1.18 1.27 
0.36 0.56 0.74 1.15 
0.33 0.81 1.12 1.17 
0.47 0.74 0.87 0.93 
0.63 
0.56 
0.24 0.48 OS6 0.77 
a The average number of remaining arginine residues in the amino-terminal position 
(see the text) 
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